Findings

What do systematic reviews say?

6 questions · 8 findings · 1 reviews · Vascular

No studies found 1 · 12.5%GRADE not reported 0 · 0%Very low 2 · 25%Low 5 · 62.5%Moderate 0 · 0%High 0 · 0%

Primary patency ( · people with peripheral vascular disease requiring below‐knee femoro‐popliteal bypass surgery

It is very uncertain whether PTFE changes primary patency (24 months) compared with PTFE with vein cuff (very low certainty).

2 findings from 1 review

Graft type for femoro‐popliteal bypass surgery 2018 · Cochrane Headline outcomes only
OR 1.08 [0.58, 2.01]
Studies not reported
Very low
Graft type for femoro‐popliteal bypass surgery 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Secondary patency (24 months) · people with peripheral vascular disease requiring below‐knee femoro‐popliteal bypass surgery

It is very uncertain whether PTFE changes secondary patency (24 months) compared with PTFE with vein cuff (very low certainty).

1 finding from 1 review

Graft type for femoro‐popliteal bypass surgery 2018 · Cochrane Headline outcomes only
OR 1.22 [0.67, 2.23]
Studies not reported
Very low

Limb salvage · people with peripheral vascular disease requiring below‐knee femoro‐popliteal bypass surgery

PTFE showed no clear difference in limb salvage (24 months) compared with PTFE with vein cuff (low certainty).

1 finding from 1 review

Graft type for femoro‐popliteal bypass surgery 2018 · Cochrane Headline outcomes only
OR 1.34 [0.72, 2.49]
Studies not reported
Low

Primary patency ( · people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery

PTFE showed no clear difference in primary patency (24 months) compared with dacron (low certainty).

2 findings from 1 review

Graft type for femoro‐popliteal bypass surgery 2018 · Cochrane Headline outcomes only
OR 1.23 [0.92, 1.65]
Studies not reported
Low
Graft type for femoro‐popliteal bypass surgery 2018 · Cochrane Headline outcomes only
OR 1.67 [0.96, 2.9]
Studies not reported
Low

Secondary patency (24 months) · people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery

PTFE may leads to higher secondary patency (24 months) compared with dacron (low certainty).

1 finding from 1 review

Graft type for femoro‐popliteal bypass surgery 2018 · Cochrane Headline outcomes only
OR 1.54 [1.04, 2.28]
Studies not reported
Low

Limb salvage · people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery

PTFE showed no clear difference in limb salvage (24 months) compared with dacron (low certainty).

1 finding from 1 review

Graft type for femoro‐popliteal bypass surgery 2018 · Cochrane Headline outcomes only
OR 0.82 [0.27, 2.48]
Studies not reported
Low